Converging evidence indicates a possible involvement of the S100B protein in the pathogenic processes of inflammatory bowel disease (IBD), a term indicating two conditions (Crohn’s disease and ulcerative colitis) that are characterized by chronic inflammation of the gastrointestinal tract. Here, S100B is linked to inflammatory bowel disease.